DCTR - Overview: Direct Antiglobulin Test (Polyspecific), Blood

Demonstrating in vivo coating of red blood cells with IgG or the complement component C3d in the following settings: -Autoimmune hemolytic anemia -Hemolytic transfusion reactions -Drug-induced hemolytic anemia

PDSU - Overview: Drug Screen, Prescription/Over the Counter, Random, Urine

Qualitative detection and identification of prescription or over-the-counter drugs frequently found in drug overdose or used with a suicidal intent Providing, when possible, the identification of all drugs in the specimen This test is not...

DIPGS - Overview: Diphtheria Toxoid IgG Antibody, Serum

Determining a patient's immunological response to diphtheria toxoid vaccination Aiding in the evaluation of immunodeficiency

DXPIN - Overview: Doxepin and Nordoxepin, Serum

Monitoring doxepin therapy Evaluating potential doxepin toxicity Evaluating patient compliance

DULOX - Overview: Duloxetine, Serum

Monitoring duloxetine serum concentration during therapy Evaluating potential duloxetine toxicity Evaluating patient compliance

FXIII - Overview: Factor XIII (13), Screen, Plasma

Screening for factor XIII deficiency

5BETH - Overview: Factor V Bethesda Units, Plasma

Detecting and quantifying the presence and titer of a specific factor inhibitor directed against coagulation factor V

F2_IS - Overview: Factor II Inhibitor Screen, Plasma

Detecting the presence of a specific factor inhibitor directed against coagulation factor II

11_IS - Overview: Factor XI Inhibitor Screen, Plasma

Detecting the presence of a specific factor inhibitor directed against coagulation factor XI

F9_IS - Overview: Factor IX Inhibitor Screen, Plasma

Detecting the presence of a specific factor inhibitor directed against coagulation factor IX

F7_IS - Overview: Factor VII Inhibitor Screen, Plasma

Detecting the presence of a specific factor inhibitor directed against coagulation factor VII

F5_IS - Overview: Factor V Inhibitor Screen, Plasma

Detecting the presence of a specific factor inhibitor directed against coagulation factor V

FL - Overview: Fluoride, Plasma

Assessing accidental fluoride ingestion Monitoring patients receiving sodium fluoride for bone disease or patients receiving voriconazole therapy

FRUCT - Overview: Fructosamine, Serum

Monitoring intermediate (1-3 weeks) glycemic control Monitoring glycemic control in patients with shortened red blood cell survival

MSFGN - Overview: Fibrillary Glomerulonephritis Confirmation, Mass Spectrometry, Paraffin Tissue

Diagnosing fibrillary glomerulonephritis

FLUOX - Overview: Fluoxetine, Serum

Monitoring serum concentration of fluoxetine during therapy Evaluating potential toxicity Evaluating patient compliance

GBETH - Overview: General Factor Bethesda Units, Plasma

Detecting and quantifying the presence and titer of a specific factor inhibitor directed against a specific coagulation factor

GPI1 - Overview: Glucose Phosphate Isomerase Enzyme Activity, Blood

The evaluation of individuals with Coombs-negative chronic hemolysis

GPIC - Overview: Glucose Phosphate Isomerase Enzyme Activity, Blood

The evaluation of individuals with Coombs-negative chronic hemolysis

LEIS - Overview: Leishmaniasis (Visceral) Antibody, Serum

Aiding in the diagnosis of active visceral leishmaniasis This test should not be used as the sole criteria for diagnosis.

MEX - Overview: Mexiletine, Serum

Assessing achievement of optimal therapeutic mexiletine concentrations Assessing potential mexiletine toxicity

LID - Overview: Lidocaine, Serum

Assessing optimal lidocaine dosing during the acute management of ventricular arrhythmias following myocardial infarction or during cardiac manipulation such as surgery Assessing potential lidocaine toxicity

URCU - Overview: Uric Acid, 24 Hour, Urine

Assessment and management of patients with kidney stones, particularly uric acid stones

TRMP - Overview: Trimipramine, Serum

Monitoring trimipramine concentration during therapy Evaluating potential trimipramine toxicity May aid in evaluating patient compliance

TOPI - Overview: Topiramate, Serum

Monitoring serum concentrations of topiramate Assessing compliance Assessing potential toxicity

URAU - Overview: Urea, 24 Hour, Urine

Assessment of protein intake and/or nitrogen balance

THEO - Overview: Theophylline, Serum

Assessing and adjusting theophylline dosage for optimal therapeutic level Assessing theophylline toxicity

VDSFT - Overview: VDRL Titer, Spinal Fluid

Aid in the diagnosis of neuroinvasive syphilis as part of a profile

VIP - Overview: Vasoactive Intestinal Polypeptide, Plasma

Detecting vasoactive intestinal polypeptide-producing tumors in patients with chronic diarrheal diseases

BILID - Overview: Bilirubin, Direct, Serum

Evaluation of jaundice and liver functions

F_12 - Overview: Coagulation Factor XII Activity Assay, Plasma

Diagnosing deficiency of coagulation factor XII Determining cause of prolonged activated partial thromboplastin time

VITE - Overview: Vitamin E, Serum

Monitoring of Vitamin E supplementation/treatment Potentially detecting Vitamin E overdoses

FHLCA - Overview: Immunoglobulin A (IgA) Heavy and Light Chain (HLC) Pairs, Kappa and Lambda with Ratio

For the quantitative measurement of human IgA heavy chain and light chain intact immunoglobulin in serum. The result can be used when monitoring previously diagnosed IgA multiple myeloma patients and is used in conjunction with other...

TOSU - Overview: Targeted Opioid Screen, Random, Urine

Determining compliance or identifying illicit opioid drug use using urine specimens This test is not intended for employment-related testing.

PRSSZ - Overview: PRSS1 Gene, Full Gene Analysis, Varies

Confirmation of suspected clinical diagnosis of hereditary pancreatitis (HP) in patients with chronic pancreatitis Identification of familial PRSSI mutation to allow for predictive and diagnostic testing in family members

ACT - Overview: Actinomyces Culture, Varies

Diagnosing anaerobic Actinomyces involved in infections

ANAE - Overview: Bacterial Culture, Anaerobic, Varies

Diagnosing anaerobic bacterial infections

BABG - Overview: Babesia microti IgG Antibodies, Serum

An adjunct in the diagnosis of babesiosis Follow-up of documented babesiosis

RA1U - Overview: Alpha-1-Microglobulin, Random, Urine

Assessment of renal tubular injury or dysfunction using random urine specimens Screening for tubular abnormalities Detecting chronic asymptomatic renal tubular dysfunction (2)

AMTRP - Overview: Amitriptyline and Nortriptyline, Serum

Monitoring amitriptyline and nortriptyline serum concentrations during therapy Evaluating potential amitriptyline and nortriptyline toxicity May aid in evaluating patient compliance

MMLRG - Overview: Antimicrobial Susceptibility, Acid-Fast Bacilli, Rapidly Growing, Varies

Determination of susceptibility of rapidly growing mycobacteria to the antimicrobial agents on the test panel

MMLYP - Overview: Antimicrobial Susceptibility Panel, Yeast, Varies

Determining in vitro quantitative antifungal susceptibility (minimum inhibitory concentration) of non-fastidious yeast As an aid in the management of certain circumstances, such as: -Refractory oropharyngeal infections due to Candida...

ASB - Overview: Arsenic, Blood

Detecting acute or very recent arsenic exposure Monitoring the effectiveness of therapy This test is not useful for evaluation of chronic arsenic exposure.

ALPRT - Overview: Alport (Collagen IV Alpha 5 and Alpha 2) Immunofluorescent Stain, Renal Biopsy

Assisting in the diagnosis of hereditary nephritis (Alport syndrome)

CTU - Overview: Creatinine, 24 Hour, Urine

Calculation of creatinine clearance, a measure of renal function, when used in conjunction with serum creatinine

F_9 - Overview: Coagulation Factor IX Activity Assay, Plasma

Diagnosing deficiencies, particularly hemophilia B (Christmas disease) Assessing the impact of liver disease on hemostasis Investigation of a prolonged activated partial thromboplastin time

HYPOG - Overview: Hypoglycemic Agent Screen, Serum

Evaluation of suspected insulinoma characterized by hypoglycemia and increased serum insulin concentration Detecting drugs that stimulate insulin secretion Drugs detected by this procedure are: -The first-generation sulfonylureas:...

IMIPR - Overview: Imipramine and Desipramine, Serum

Monitoring imipramine and desipramine concentrations during therapy Evaluating potential imipramine and desipramine toxicity May aid in evaluating patient compliance

ANCA2 - Overview: Cytoplasmic Neutrophil Antibodies, Inflammatory Bowel Disease Panel, Serum

Measurement of antineutrophil cytoplastic antibodies as a part of a profile to aid in distinguishing between ulcerative colitis and Crohn disease in patients for whom the specific diagnosis is unclear based on endoscopic, pathologic, and...

THEVI - Overview: Hemoglobinopathy Interpretation

Interpretation of results for the evaluation of thalassemias and hemoglobinopathies Evaluation of microcytosis Extensive and economical diagnosis and classification of hemoglobinopathies or thalassemia including complex...